OMNICLAV 375

Description

OMNICLAV 375 Tablet is a combination antibiotic manufactured by Cipla Ltd., containing Amoxicillin 250 mg and Potassium Clavulanate 125 mg. This combination enhances the effectiveness of Amoxicillin against beta-lactamase producing bacteria, which may otherwise resist standard penicillin therapy.

• Amoxicillin works by inhibiting bacterial cell wall synthesis, killing susceptible bacteria.

• Potassium Clavulanate inhibits beta-lactamase enzymes, protecting Amoxicillin from degradation and extending its antibacterial activity.

This combination provides broad-spectrum coverage for respiratory, urinary, skin, and other bacterial infections.

Uses:

• Respiratory tract infections: Tonsillitis, pharyngitis, sinusitis, bronchitis, pneumonia

• Ear, nose, and throat infections

• Urinary tract infections (UTIs)

• Skin and soft tissue infections

• Dental infections

Key Benefits:

• Effective against beta-lactamase producing bacteria

• Provides relief from fever, pain, swelling, and redness caused by bacterial infections

• Helps prevent recurrence and spread of infection

• Trusted quality from Cipla Ltd.

How to Take:

• Take as prescribed by your doctor

• Swallow the tablet whole with water, preferably after meals

• Complete the full prescribed course, even if symptoms improve early

Precautions:

• Not effective against viral infections like cold or flu

• Inform your doctor if allergic to penicillins or clavulanate

• Use with caution in patients with kidney or liver disease

• Pregnant or breastfeeding women should take only if advised by a doctor

Possible Side Effects:

• Common: Nausea, vomiting, diarrhea, stomach pain, mild rash

• Rare but serious: Severe allergic reactions, persistent diarrhea (C. difficile infection)

Storage:

• Store in a cool, dry place below 25°C

• Keep out of reach of children and away from direct sunlight